Delivery Order SPE2DB20D2104-SPE2DB23FT56S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,739.23 Firm Fixed Price Delivery Order contract has an ultimate completion date of November 29, 2023 and covers the supply of Fosamax 70 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, to provide Fosamax 70 mg tablets. The firm fixed price delivery order has a ceiling value of $1,362.82 and a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,313.70, is a Firm Fixed Price Delivery Order to supply the government with FOSAMAX 70 MG TABLET medication. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of FOSAMAX 70 MG Tablets. The $3,453.43 Firm Fixed Price contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,403.54 firm fixed-price contract is for the supply of Fosamax 70 mg tablets and has a completion date of March 12, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Fosamax 70 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,170.74, and has an ultimate completion date of April 23, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor on this award. The company holds a significant Indefinite Delivery...
- This federal contract award, valued at $2,896.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a completion date of July 2, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of FOSAMAX 70 mg tablets. The $1,488.76 firm fixed-price delivery order has a completion date of December 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,755.91 delivery order contract is for the supply of FOSAMAX 70 MG TABLET medication, with a performance period through December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing a comprehensive range of...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The award has a ceiling value of $2,044.32 and an ultimate completion date of March 18, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT56SDelivery Order
This federal contract award, valued at $6,154.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,970,251 units of the medication Fosamax 70 mg tablet, with a completion date of May 18, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 5/17/23 |